MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Retrospective Medical Record Review of Mind Body Depression Group Participants

Completed

Conditions: Depression
Anxiety

First Posted Date: 2013-07-29

Last Posted Date: 2016-05-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 156

Registration Number: NCT01909921

Cardiac Fibrosis by CMR in Patients With Cancer

Withdrawn

Conditions: Lymphoma

Interventions: Device: Cardiac Magnetic Resonance Scan

First Posted Date: 2013-07-24

Last Posted Date: 2018-09-14

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT01906437

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Insitute, Boston, Massachusetts, United States

Cholecalciferol Supplementation for Sepsis in the ICU

Phase 3

Completed

Conditions: Hypovitaminosis D

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Cholecalciferol

First Posted Date: 2013-07-11

Last Posted Date: 2016-06-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT01896544

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pilot Study of Cognitive Behavioral Therapy for Anxiety and Bipolar I Disorder

Not Applicable

Completed

Conditions: Bipolar Disorder
Anxiety Disorders

Interventions: Behavioral: UP CBT
Drug: Treatment as usual

First Posted Date: 2013-07-04

Last Posted Date: 2017-05-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 34

Registration Number: NCT01892306

Locations: 🇺🇸
Massachusetts General Hospital Bipolar Clinic and Research Program, Boston, Massachusetts, United States

Tivozanib + Enzalutamide in Adv Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Tivozanib
Drug: Enzalutamide

First Posted Date: 2013-06-25

Last Posted Date: 2024-03-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT01885949

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Changing Pediatric Office Systems Nationally to Address Parental Tobacco Use

Not Applicable

Completed

Conditions: Tobacco Dependence

Interventions: Behavioral: CEASE Intervention

First Posted Date: 2013-06-20

Last Posted Date: 2019-04-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 3888

Registration Number: NCT01882348

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Using SMART Experimental Design to Personalize Treatment for Child Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Cognitive Behavioral Therapy (CBT)
Behavioral: Caregiver-Child Treatment

First Posted Date: 2013-06-19

Last Posted Date: 2021-09-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 44

Registration Number: NCT01880814

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence

Phase 2

Completed

Conditions: Relapse
Recurrence
Depression, Unipolar
Major Depressive Disorder

Interventions: Drug: Placebo
Drug: Naltrexone

First Posted Date: 2013-06-11

Last Posted Date: 2017-02-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT01874951

Locations: 🇺🇸
Massachusetts General Hospital; Depression Research and Clinical Program, Boston, Massachusetts, United States

An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

Phase 4

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Drug: Naltrexone

First Posted Date: 2013-06-10

Last Posted Date: 2017-01-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 3

Registration Number: NCT01873729

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Endoscopic Myotomy for the Treatment of Achalasia (Motility Disorder) of the Esophagus - POEM Procedure

Phase 1

Completed

Conditions: Achalasia

Interventions: Procedure: Endoscopic Esophageal Myotomy

First Posted Date: 2013-06-10

Last Posted Date: 2015-04-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT01873300

Locations: 🇺🇸
Masschusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy